NUTANIX ($NTNX) is expected to release its quarterly earnings data on Tuesday, November 25th after market close, per Finnhub. Analysts are expecting revenue of $690,284,918 and earnings of $0.42 per share.
You can see Quiver Quantitative's $NTNX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NUTANIX Insider Trading Activity
NUTANIX insiders have traded $NTNX stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $NTNX stock by insiders over the last 6 months:
- GROEN MAX PIETER DE sold 5,480,467 shares for an estimated $420,954,670
- RAJIV RAMASWAMI (President and CEO) has made 0 purchases and 3 sales selling 146,632 shares for an estimated $11,203,575.
- STEVEN J GOMO sold 15,000 shares for an estimated $1,126,515
- RUKMINI SIVARAMAN (Chief Financial Officer) has made 0 purchases and 3 sales selling 13,491 shares for an estimated $1,045,152.
- BRIAN MARTIN (Chief Legal Officer) sold 10,241 shares for an estimated $783,731
- VIRGINIA GAMBALE sold 7,000 shares for an estimated $546,000
- TERESA GAYLE SHEPPARD has made 0 purchases and 2 sales selling 3,500 shares for an estimated $267,691.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NUTANIX Hedge Fund Activity
We have seen 366 institutional investors add shares of NUTANIX stock to their portfolio, and 317 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 10,929,163 shares (+54.0%) to their portfolio in Q3 2025, for an estimated $813,020,435
- STATE STREET CORP added 3,676,595 shares (+69.0%) to their portfolio in Q3 2025, for an estimated $273,501,902
- MARSHALL WACE, LLP removed 2,649,102 shares (-80.8%) from their portfolio in Q3 2025, for an estimated $197,066,697
- AQR CAPITAL MANAGEMENT LLC added 1,914,005 shares (+40.6%) to their portfolio in Q3 2025, for an estimated $142,382,831
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,910,064 shares (+110.5%) to their portfolio in Q3 2025, for an estimated $142,089,660
- PICTET ASSET MANAGEMENT HOLDING SA added 1,548,023 shares (+56.0%) to their portfolio in Q3 2025, for an estimated $115,157,430
- ROYAL BANK OF CANADA removed 1,424,126 shares (-45.3%) from their portfolio in Q3 2025, for an estimated $105,940,733
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NUTANIX Analyst Ratings
Wall Street analysts have issued reports on $NTNX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 11/17/2025
- JP Morgan issued a "Overweight" rating on 11/17/2025
- Needham issued a "Buy" rating on 08/28/2025
- Barclays issued a "Overweight" rating on 08/28/2025
- B of A Securities issued a "Buy" rating on 08/28/2025
- Goldman Sachs issued a "Buy" rating on 07/15/2025
- Keybanc issued a "Overweight" rating on 06/26/2025
To track analyst ratings and price targets for NUTANIX, check out Quiver Quantitative's $NTNX forecast page.
NUTANIX Price Targets
Multiple analysts have issued price targets for $NTNX recently. We have seen 11 analysts offer price targets for $NTNX in the last 6 months, with a median target of $88.0.
Here are some recent targets:
- Param Singh from Oppenheimer set a target price of $90.0 on 11/17/2025
- Samik Chatterjee from JP Morgan set a target price of $78.0 on 11/17/2025
- Mike Cikos from Needham set a target price of $80.0 on 08/28/2025
- Tim Long from Barclays set a target price of $82.0 on 08/28/2025
- Wamsi Mohan from B of A Securities set a target price of $93.0 on 08/28/2025
- Aaron Rakers from Wells Fargo set a target price of $71.0 on 08/28/2025
- Matthew Martino from Goldman Sachs set a target price of $95.0 on 07/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
